Keywords
Clinical Conditions
Equipment & Techniques
I am using neuroimaging to study why some people with Parkinson’s disease develop dementia. My project examines how glymphatic dysfunction, microglial neuroinflammation and alpha-synuclein aggregation interact, using PET/MR data (DTI-ALPS, [11C]PK-11195 PET) and CSF seeding assays to link these mechanisms to long-term cognitive outcomes.
